Immediate Management of Established Coronary Artery Disease
All patients with established coronary artery disease require immediate initiation of aspirin 75-100 mg daily, high-intensity statin therapy, and short-acting nitrates for symptom relief, combined with aggressive lifestyle modification including exercise-based cardiac rehabilitation. 1, 2, 3, 4
Pharmacological Management for Event Prevention (Start Immediately)
Antiplatelet Therapy
- Aspirin 75-100 mg daily is mandatory as the foundation of antithrombotic therapy for all patients with established CAD 1, 2, 4
- Clopidogrel 75 mg daily serves as the alternative if aspirin is not tolerated 2, 4
- If the patient has undergone coronary stent placement, dual antiplatelet therapy (aspirin plus clopidogrel) must continue for 6 months 4
Lipid Management
- Initiate high-intensity statin therapy immediately in all patients with established CAD to reduce major vascular events and mortality 1, 2, 3, 4
- Add ezetimibe if LDL goals are not achieved with maximum tolerated statin dose 2, 3, 4
- For very high-risk patients not reaching LDL targets on statin plus ezetimibe, add a PCSK9 inhibitor 2, 4
Blood Pressure Management
- ACE inhibitors (or ARBs if ACE inhibitors not tolerated) are recommended, particularly when hypertension, diabetes, heart failure, or left ventricular dysfunction coexist 1, 2, 4
- Target office blood pressure to 120-130 mmHg systolic (130-140 mmHg in patients >65 years) 1
- Never combine ACE inhibitors with ARBs 1
Pharmacological Management for Symptom Control
First-Line Symptomatic Treatment
- Beta-blockers are first-line for controlling heart rate and relieving angina symptoms 1, 2, 3, 4
- Beta-blockers are particularly recommended in patients with recent myocardial infarction 1
Alternative Symptomatic Treatment
- Calcium channel blockers are appropriate when beta-blockers are contraindicated or poorly tolerated 1, 2, 3, 4
- In patients with symptomatic angina, beta-blockers and/or calcium channel blockers can be combined 1
Immediate Relief Medication
- Prescribe short-acting nitrates (sublingual nitroglycerin) to all patients for immediate relief of effort angina 1, 2, 3, 4
- Critical pitfall: Never use nitrates in patients with hypertrophic obstructive cardiomyopathy or in combination with phosphodiesterase inhibitors 2, 3
Essential Lifestyle Modifications (Initiate Immediately)
Cardiac Rehabilitation
- Exercise-based cardiac rehabilitation is fundamental and must be initiated as it significantly reduces cardiovascular mortality and morbidity while improving risk factor control 2, 3, 4
Preventive Measures
- Annual influenza vaccination is recommended, especially in elderly patients, to reduce mortality risk 2, 3, 4
- Smoking cessation must be addressed immediately 1
Psychological Support
- Implement psychological interventions to address depression symptoms 2, 4
- Cognitive behavioral interventions help achieve and maintain healthy lifestyle changes 2
Gastrointestinal Protection
- Proton pump inhibitors are recommended for patients on aspirin who have high gastrointestinal bleeding risk 2
Risk Stratification and Follow-Up
Initial Assessment
- Assess symptom severity, risk factors, and comorbidities to guide treatment decisions 3
- Evaluate for left ventricular ejection fraction <50%, which indicates higher risk 1
- Identify high-risk features: left main disease, multivessel disease with LV dysfunction, multivessel disease with diabetes 1
Monitoring Schedule
- Review patient response to medical therapies at 2-4 weeks after drug initiation 2, 4
- Clinical follow-up at least annually to assess symptoms, functional status, and adherence 4
- Patient education about the disease, risk factors, and treatment strategy is essential for long-term adherence 2, 3, 4
When to Consider Revascularization
High-Risk Indications for Urgent Invasive Coronary Angiography
- Severe symptoms refractory to maximal medical therapy 1, 4
- Recurrent ischemia (recurrent chest pain or dynamic ST-segment changes) 1
- Elevated troponin levels 1
- Hemodynamic instability 1
- Major arrhythmias (repetitive ventricular tachycardia, ventricular fibrillation) 1
Anatomical Indications for Revascularization
- Left main coronary artery disease 1, 4
- Multivessel disease with reduced LV function 1
- Multivessel disease with diabetes mellitus 1
- High-risk noninvasive ischemia testing (>10% of LV mass ischemic) 1
Critical Pitfall
- Medical therapy must be optimized before considering revascularization, except in high-risk patients with significant symptoms despite medical therapy 3, 4
- Do not pursue coronary angiography solely for risk stratification 1, 2
- Coronary CTA is not recommended as a routine follow-up test for patients with established CAD 1